C2
protein-codingcomplement C2, the group of Complement system activation components|Sushi domain containing
Gene summary
Component C2 is a serum glycoprotein that functions as part of the classical pathway of the complement system. Activated C1 cleaves C2 into C2a and C2b. The serine proteinase C2a then combines with complement factor 4b to create the C3 or C5 convertase. Deficiency of C2 has been reported to associated with certain autoimmune diseases and SNPs in this gene have been associated with altered susceptibility to age-related macular degeneration. This gene localizes within the class III region of the MHC on the short arm of chromosome 6. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been described in publications but their full-length sequence has not been determined.[provided by RefSeq, Mar 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~47.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009006
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009006
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Renal
Intervention: Allergy/Immunology/Infectious
Rationale: Antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial for infectious manifestations; Patients may also develop autoimmune manifestations, and treatment with immune modulators has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to C2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000063.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 98 | 1 | 105 | |
| missense | 1 | 194 | 32 | 227 | ||
| nonsense | 6 | 1 | 3 | 10 | ||
| start loss | 0 | |||||
| frameshift | 9 | 2 | 11 | |||
| splice donor/acceptor (+/-2bp) | 1 | 9 | 1 | 11 | ||
| Total | 18 | 12 | 202 | 131 | 1 | 364 |
Highest pathogenic variant AF is 0.0057364567
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000054.2 | 18 | MANE Select | |
| Ensembl | ENSP00000299367.5 | 18 | MANE Select | |
| RefSeq | NP_001139375.1 | 16 | Standard | |
| RefSeq | NP_001171534.1 | 14 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Complement and coagulation cascades - Homo sapiens (human)
- Pertussis - Homo sapiens (human)
- Systemic lupus erythematosus - Homo sapiens (human)
- Staphylococcus aureus infection - Homo sapiens (human)
- Allograft Rejection
Biological Process
- proteolysis
- complement activation
- complement activation, classical pathway
- response to nutrient
- regulation of complement activation
Molecular Function
- serine-type endopeptidase activity
- protein binding
- metal ion binding
Cellular Component
- extracellular region
- extracellular space
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000299367
- Coding exons
- 18
- Length
- 47888
- Individuals with no LoFs
- 124496
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 1250
- Defined
- 125748
- p
- 0.00499
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.12 | 361 | 426 | 0.847 | 0.0000266 | 4954 |
| Missense (PolyPhen) | 128 | 169.65 | 0.75448 | 1985 | ||
| Synonymous | 1.06 | 151 | 168 | 0.896 | 0.0000108 | 1478 |
| Loss of Function | 1.42 | 30 | 39.6 | 0.757 | 0.00000232 | 421 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0011 | 0.0010 | notable |
| Latino/Admixed American | 0.0040 | 0.0040 | notable |
| Ashkenazi Jewish | 0.012 | 0.012 | notable |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0.0052 | 0.0051 | notable |
| European (Non-Finnish) | 0.0073 | 0.0073 | notable |
| South Asian | 0.00056 | 0.00056 | rare |
| Other | 0.0044 | 0.0044 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component C2 which is part of the classical pathway of the complement system is cleaved by activated factor C1 into two fragments: C2b and C2a. C2a, a serine protease, then combines with complement factor C4b to generate the C3 or C5 convertase.;
- Disease
- DISEASE: Complement component 2 deficiency (C2D) [MIM:217000]: A rare defect of the complement classical pathway associated with the development of autoimmune disorders, mainly systemic lupus erythematosus. Skin and joint manifestations are common and renal disease is relatively rare. Patients with complement component 2 deficiency are also reported to have recurrent invasive infections. {ECO:0000269|PubMed:8621452, ECO:0000269|PubMed:9670930}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- LoFtool
- 0.260
- RVIS EVS
- -0.07
- RVIS percentile EVS
- 48.78
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.895
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |